Last Price
42.07
Today's Change
+4.58 (12.21%)
Day's Change
35.68 - 42.07
Trading Volume
188,279
Market Cap
273 Million
Shares Outstanding
6 Million
Avg Volume
250,834
Avg Price (50 Days)
32.41
Avg Price (200 Days)
16.29
PE Ratio
-2.29
EPS
-18.39
Earnings Announcement
11-Nov-2024
Previous Close
37.49
Open
37.41
Day's Range
35.68 - 42.07
Year Range
6.08 - 92.0
Trading Volume
188,534
1 Day Change
12.22%
5 Day Change
-11.95%
1 Month Change
-9.45%
3 Month Change
230.74%
6 Month Change
285.96%
Ytd Change
441.44%
1 Year Change
476.14%
3 Year Change
-88.38%
5 Year Change
-92.04%
10 Year Change
-92.04%
Max Change
-92.04%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 to recognize folate receptor alpha (FOLR1) with indications, including gynecological, non-small cell lung cancer, renal caner, and others. The company was incorporated in 2018 and is headquartered in Dallas, Texas.